1.1 | Base services on assessed community need | 0 |
1.2 | Provide SRH services through multisectoral action | 0 |
1.3 | History of the field manual | 0 |
1.4 | Development of the 2018 edition | 0 |
1.5 | What changed in the 2018 edition | 0 |
1.6 | Intended readership of the manual | 0 |
1.7 | Where to find further resources | 0 |
10.1 | Chapter scope on gender-based violence | 0 |
10.3.1 | Deliver MISP sexual violence care | 0 |
10.3.2 | Assess GBV within SRH planning | 0 |
10.3.3a | Adapt GBV programming to context | 0 |
10.3.3b | Clinical care for sexual violence | 0 |
10.3.3c | Detect and respond to intimate partner violence | 0 |
10.3.3d | Respond to female genital cutting | 0 |
10.3.3e | SRH care for married adolescents | 0 |
10.3.3f | SRH services for trafficked persons | 0 |
10.3.4a | Psychosocial support from first contact | 0 |
10.3.4b | Community based psychosocial activities | 0 |
10.3.5a | Agree multi-sectoral GBV procedures | 0 |
10.3.5b | Health sector duties under GBV SOPs | 0 |
10.3.6 | Advocate against harmful practices | 0 |
10.4 | Human rights basis for GBV response | 0 |
10.4.1 | Apply survivor-centred guiding principles | 0 |
10.4.2 | Handle legal and cultural dilemmas | 0 |
10.5 | Monitor and report GBV indicators | 0 |
11.1 | HIV in humanitarian settings: chapter introduction | 0 |
11.2 | Chapter objectives for HIV programming | 0 |
11.3 | Factors to weigh in HIV programme planning | 0 |
11.3.1a | Build HIV into preparedness and contingency plans | 0 |
11.3.1b | Keep drugs and commodities flowing | 0 |
11.3.1c | Leadership to place ARVs in the response | 0 |
11.3.2 | Deliver the MISP HIV and STI package | 0 |
11.3.3a | Joint HIV needs assessment | 0 |
11.3.3b | Review HIV law and policy | 0 |
11.3.3c | Tailor programming to the local epidemic | 0 |
11.3.5a | Workforce planning, task-sharing and task-shifting | 0 |
11.3.5b | Assess capacity gaps and train staff | 0 |
11.3.5c | Reaching refugees and IDPs in urban areas | 0 |
11.3.5d | Tailored services for key populations | 0 |
11.3.5e | Enabling environment and community-led responses | 0 |
11.3.6a | Scale up from MISP to comprehensive services | 0 |
11.3.6b | Awareness campaigns and tailored communication | 0 |
11.3.6c | Combination HIV prevention package | 0 |
11.3.6d | Quality voluntary HIV counselling and testing | 0 |
11.3.6e | Provider-initiated testing and counselling | 0 |
11.3.6f | Retest before enrolling in HIV care | 0 |
11.3.6g | Post-exposure prophylaxis after exposure | 0 |
11.3.6h | Services to stop mother to child transmission | 0 |
11.3.6i | Infant feeding for mothers living with HIV | 0 |
11.3.6j | Offer oral pre-exposure prophylaxis | 0 |
11.3.7a | Keep antiretroviral treatment uninterrupted | 0 |
11.3.7b | Criteria for starting antiretroviral therapy | 0 |
11.3.7c | Preparations before ART services open | 0 |
11.3.7d | Emotional and social support for HIV-positive people | 0 |
11.3.7e | Patient information, water and malaria protection | 0 |
11.3.7f | Support for treatment adherence | 0 |
11.3.7g | TB treatment and opportunistic infection prophylaxis | 0 |
11.3.7h | Family planning for people living with HIV | 0 |
11.3.7i | Food and nutrition support | 0 |
11.3.7j | Community, home-based and palliative care | 0 |
11.3.7k | Care for children living with HIV | 0 |
11.3.8 | Coordinate and link HIV with other services | 0 |
11.3.9a | Advocacy for access and national policy | 0 |
11.3.9b | Advocacy on rights and structural barriers | 0 |
11.4a | Rights that govern HIV services | 0 |
11.4b | Handling conflicts between law and rights | 0 |
11.5 | Monitoring and evaluating the HIV response | 0 |
12.1 | Chapter scope and STI versus RTI terms | 0 |
12.3.1 | STI services in the MISP | 0 |
12.3.2 | Provide the complete set of STI public health services | 0 |
12.3.3a | STI content in SRH needs assessments | 0 |
12.3.3b | Review national STI law, policy and protocols | 0 |
12.3.4a | Safer sex promotion in communities | 0 |
12.3.4b | Condom programming and distribution | 0 |
12.3.4c | Public awareness and stigma reduction | 0 |
12.3.5a | Comprehensive case management at first contact | 0 |
12.3.5b | Clinical, laboratory and rapid diagnosis | 0 |
12.3.5c | No-missed-opportunities screening | 0 |
12.3.5d | Treatment protocols adapted to local resistance | 0 |
12.3.5e | Patient education and confidential counselling | 0 |
12.3.5f | Partner notification, referral and treatment | 0 |
12.3.5g | Follow-up and assessment of non-response | 0 |
12.3.5h | Quality of care and staff competency | 0 |
12.3.6a | Integrate STI care into primary and SRH services | 0 |
12.3.6b | STI care in pregnancy and childbirth | 0 |
12.3.6c | Cervical cancer prevention in SRH services | 0 |
12.3.7 | Advocacy for STI services and investment | 0 |
12.4.1 | Handling barriers and ethical dilemmas | 0 |
12.4a | Rights-based access and confidentiality | 0 |
12.4b | Right to information and new technologies | 0 |
12.5 | STI programme monitoring indicators | 0 |
2.1 | Purpose of the fundamental principles | 0 |
2.3 | Four principles for SRH programming | 0 |
2.3.1 | Work in respectful partnership | 0 |
2.3.2 | Uphold human rights and reproductive rights | 0 |
2.3.3 | Ensure technical, rights and financial accountability | 0 |
2.3.4 | Share information and results | 0 |
3.1 | Introduction and scope of the MISP chapter | 0 |
3.2 | Chapter objectives and intended audience | 0 |
3.3.1 | Name a lead SRH organization at the outset | 0 |
3.3.1a | Assign a coordinator who supports all health agencies | 0 |
3.3.1b | Convene regular SRH coordination meetings | 0 |
3.3.1c | Report MISP progress to cluster and sub-cluster | 0 |
3.3.1d | Map and analyse existing SRH services | 0 |
3.3.1e | Circulate information on SRH services and commodities | 0 |
3.3.1f | Tell communities where SRH services are | 0 |
3.3.1g | Orient partners on the MISP and RH kits | 0 |
3.3.1h | Compile population and SRH baseline information | 0 |
3.3.1i | Coordinate RH kit procurement and distribution | 0 |
3.3.1j | Monitor MISP services with age and sex data | 0 |
3.3.1k | Help partners access humanitarian SRH funding | 0 |
3.3.1l | Plan the move to comprehensive SRH services | 0 |
3.3.1m | Identify skilled staff and confidential referral links | 0 |
3.3.1n | Engage adolescents and support adolescent-friendly services | 0 |
3.3.1o | Track laws and policies that shape SRH access | 0 |
3.3.2a | Put sexual violence prevention measures in place | 0 |
3.3.2b | Make clinical care and referral available to survivors | 0 |
3.3.2c | Provide confidential and safe spaces in facilities | 0 |
3.3.2d | Design facilities for safety, security and access | 0 |
3.3.2e | Recruit female providers, chaperones and interpreters | 0 |
3.3.2f | Protect survivor confidentiality and enforce SEA codes | 0 |
3.3.2g | Respect survivor rights and let survivors choose | 0 |
3.3.2h | Provide first-line support wherever people make contact | 0 |
3.3.2i | Use the agreed examination and treatment protocol | 0 |
3.3.2j | Offer emergency contraception within 120 hours | 0 |
3.3.2k | Give presumptive treatment for sexually transmitted infections | 0 |
3.3.2l | Start HIV post-exposure prophylaxis within 72 hours | 0 |
3.3.2m | Offer hepatitis B and HPV vaccination | 0 |
3.3.2n | Clean wounds and give tetanus prophylaxis | 0 |
3.3.2o | Offer pregnancy testing and unbiased options counselling | 0 |
3.3.2p | Document findings and handle forensic evidence properly | 0 |
3.3.2q | Agree referral roles and GBV standard operating procedures | 0 |
3.3.2r | Keep referral and transport running around the clock | 0 |
3.3.2s | Schedule follow-up care over six months | 0 |
3.3.2t | Tell communities about the 72 and 120 hour limits | 0 |
3.3.2u | Apply child-specific consent, reporting and clinical rules | 0 |
3.3.2v | Adapt services for at-risk groups | 0 |
3.3.3a | Establish safe and rational blood transfusion | 0 |
3.3.3b | Apply standard precautions in every health setting | 0 |
3.3.3c | Manage occupational exposure and supply PEP to staff | 0 |
3.3.3d | Guarantee free lubricated male and female condoms | 0 |
3.3.3e | Continue antiretroviral treatment without interruption | 0 |
3.3.3f | Offer PEP to survivors after sexual violence | 0 |
3.3.3g | Provide co-trimoxazole prophylaxis for people with HIV | 0 |
3.3.3h | Provide syndromic diagnosis and treatment of STIs | 0 |
3.3.3i | Tie MISP work to the national HIV programme | 0 |
3.3.4a | Skilled birth attendance and newborn care at health centres | 0 |
3.3.4aa | Newborn care at hospital level | 0 |
3.3.4ab | Community recognition of newborn danger signs | 0 |
3.3.4ac | Clinical danger signs for treating neonatal infection | 0 |
3.3.4ad | Life saving drugs and supplies in health centres | 0 |
3.3.4ae | Capabilities of providers at specialised hospitals | 0 |
3.3.4af | Competencies required of skilled birth attendants | 0 |
3.3.4ag | Kangaroo care for premature and small newborns | 0 |
3.3.4ah | Round the clock referral system for emergencies | 0 |
3.3.4ai | Written referral procedures and posted protocols | 0 |
3.3.4aj | Informing communities where to seek emergency care | 0 |
3.3.4ak | Fallback when round the clock referral is impossible | 0 |
3.3.4al | Post-abortion care available in centres and hospitals | 0 |
3.3.4am | Definitive management and stabilisation before transfer | 0 |
3.3.4an | Tetanus prophylaxis after unsafe abortion | 0 |
3.3.4ao | Contraception for every post-abortion care client | 0 |
3.3.4ap | Clean delivery package for pregnant women | 0 |
3.3.4aq | Kits and supplies for traditional birth attendants | 0 |
3.3.4ar | Linking traditional birth attendants to clinics | 0 |
3.3.4b | Thermal protection of the newborn | 0 |
3.3.4c | Clean delivery kits for home births | 0 |
3.3.4d | Clean birth practices and hygiene at delivery | 0 |
3.3.4e | Promoting birth in a health facility | 0 |
3.3.4f | Newborn feeding support | 0 |
3.3.4g | Frequent newborn danger sign checks | 0 |
3.3.4h | Management of intrapartum complications | 0 |
3.3.4i | Postnatal checks in the first week | 0 |
3.3.4j | Round the clock basic and comprehensive EmONC | 0 |
3.3.4k | Partograph use and action on findings | 0 |
3.3.4l | Newborn resuscitation following the HBB chart | 0 |
3.3.4m | Chlorhexidine for cord care after home births | 0 |
3.3.4n | Clean dry cord care in low mortality settings | 0 |
3.3.4o | Comprehensive EmONC through host hospitals | 0 |
3.3.4p | Basic EmONC at every health centre | 0 |
3.3.4q | Signal function one, parenteral antibiotics for sepsis | 0 |
3.3.4r | Signal function two, uterotonics for postpartum haemorrhage | 0 |
3.3.4s | Signal function three, anticonvulsants for eclampsia | 0 |
3.3.4t | Signal function four, assisted vaginal delivery | 0 |
3.3.4u | Signal function five, manual removal of placenta | 0 |
3.3.4v | Signal function six, clearing retained pregnancy tissue | 0 |
3.3.4w | Signal function seven, basic newborn resuscitation | 0 |
3.3.4x | Signal function eight, caesarean surgery | 0 |
3.3.4y | Signal function nine, safe blood transfusion | 0 |
3.3.4z | Newborn care at health facility level | 0 |
3.3.5a | Range of contraceptives at primary care level | 0 |
3.3.5b | Methods supplied where providers can insert and remove | 0 |
3.3.5c | Contraceptive information and counselling quality | 0 |
3.3.5d | Existing provider skills used from the outset | 0 |
3.3.5e | Confidential provision without third party consent | 0 |
3.3.5f | Community awareness of contraceptive services | 0 |
3.3.5g | Condoms available and dual protection counselling | 0 |
3.3.5h | Emergency contraception without eligibility barriers | 0 |
3.3.6a | Planning comprehensive SRH integration from the onset | 0 |
3.3.6b | Enablers required for comprehensive SRH planning | 0 |
3.3.6c | Joint planning to place SRH within national health systems | 0 |
3.3.6d | Choosing where to deliver comprehensive SRH services | 0 |
3.3.6e | Assessing staff capacity and planning training | 0 |
3.3.6f | SRH data and its place in the health information system | 0 |
3.3.6g | SRH commodity management and ordering | 0 |
3.3.6h | Longer term financing for comprehensive SRH | 0 |
3.3.6i | Governance, policy review and community accountability | 0 |
3.3.7a | Reproductive health kits as the MISP supply route | 0 |
3.3.7b | Kit levels, population coverage and shelf life | 0 |
3.3.7c | Procurement sources and supplier independence | 0 |
3.3.7d | In-country kit distribution and cold chain plan | 0 |
3.3.7e | Import, customs clearance and port collection | 0 |
3.3.7f | Conditions for complementary commodities | 0 |
3.3.8a | Timing for the other SRH priorities | 0 |
3.3.8b | Safe abortion care as far as national law permits | 0 |
3.3.8c | Information, method and counselling for women choosing abortion | 0 |
3.3.8d | Supplies and regimen for safe abortion care | 0 |
3.4a | The legal foundation for the MISP | 0 |
3.4b | Advocacy when the MISP is deprioritised | 0 |
3.5a | MISP checklist monitoring at the onset | 0 |
3.5b | Routine monitoring and closing coverage gaps | 0 |
4.1 | Chapter introduction and supply chain rationale | 0 |
4.2 | What this chapter covers | 0 |
4.3.1 | Supply chain principles for emergency settings | 0 |
4.3.2a | Use pre-crisis data for early logistics planning | 0 |
4.3.2b | Data points needed for logistics decisions | 0 |
4.3.2c | Embed SRH supplies in the health cluster pipeline | 0 |
4.3.2d | Set RH Kit quantities from the catchment population | 0 |
4.3.2e | Use facility data for kit choice and distribution | 0 |
4.3.2f | Put partner agreements in place for RH Kits | 0 |
4.3.2g | Share RH Kit weight and volume specifications | 0 |
4.3.2h | Satisfy government import and registration rules | 0 |
4.3.2i | Adopt consistent inventory and reporting tools | 0 |
4.3.2j | Assess logistics staffing and coordination mechanisms | 0 |
4.3.2k | Identify medical waste management rules | 0 |
4.3.2l | Plan transport, warehousing and cold chain | 0 |
4.3.2m | Assess and plan the transition to sustainable supply | 0 |
4.3.2n | Base orders on stock and consumption records | 0 |
4.3.2o | Check government policy and local drug quality | 0 |
4.3.3a | Assign supply chain roles and fund logisticians | 0 |
4.3.3b | Forecast and quantify commodities across the cycle | 0 |
4.3.3c | Buy only products with assured quality | 0 |
4.3.3d | Specify orders precisely and confirm import eligibility | 0 |
4.3.3e | Clear customs and manage product entry | 0 |
4.3.3f | Store and transport products without quality loss | 0 |
4.3.3g | Plan and safeguard last-mile delivery | 0 |
4.3.3h | Deploy tracking and tracing tools by phase | 0 |
4.3.3i | Build staff capacity for logistics data | 0 |
4.3.3j | Audit stock and act on accountability data | 0 |
4.3.4a | Coordinate with clusters and the UNFPA focal point | 0 |
4.3.4b | Coordinate with partners and government agencies | 0 |
4.3.4c | Work with health staff, vendors and local suppliers | 0 |
4.3.4d | Embed logistics in organisational strategy | 0 |
4.3.5a | Advocate with national decision-makers | 0 |
4.3.5b | Engage local and community leaders in preparedness | 0 |
4.3.5c | Ask donors to fund supply chain capacity | 0 |
4.3.5d | Provide technical justification for contested products | 0 |
4.4a | Human rights standards for SRH supplies | 0 |
4.4b | Ensure safe access for marginalised groups | 0 |
4.4c | Balance local sourcing with product quality | 0 |
4.5a | Set organisational logistics indicators | 0 |
4.5b | Track priority supply chain indicators | 0 |
5.1 | Purpose of assessment, monitoring and evaluation | 0 |
5.2 | Objectives for assessment and monitoring | 0 |
5.3 | Linked assessment, monitoring and evaluation cycle | 0 |
5.3.1a | Rapid assessment information for MISP planning | 0 |
5.3.1b | Desk review of secondary SRH data | 0 |
5.3.1c | Assessment team skills and composition | 0 |
5.3.1d | Participatory and inclusive assessment methods | 0 |
5.3.1e | Situational analysis of context | 0 |
5.3.1f | Service mapping and health facility assessment | 0 |
5.3.1g | Key informant interviews and focus groups | 0 |
5.3.1h | Survey design and representativeness | 0 |
5.3.1i | Data collection planning and safeguards | 0 |
5.3.1j | Analysis, reporting and use of assessment results | 0 |
5.3.2a | Monitoring within existing health systems | 0 |
5.3.2b | Standard tools and emergency monitoring system | 0 |
5.3.2c | Routine data sources and disaggregation | 0 |
5.3.2d | Monitoring frequency and timely reporting | 0 |
5.3.2e | Monitoring roles, training and data quality | 0 |
5.3.2f | Indicator selection, targets and balance | 0 |
5.3.2g | Feedback and use of monitoring results | 0 |
5.3.3a | Evaluation timing and planning | 0 |
5.3.3b | Independent external evaluators | 0 |
5.3.3c | Evaluation methods and questions | 0 |
5.3.3d | Use and sharing of evaluation findings | 0 |
5.4.1a | Confidentiality of reproductive health information | 0 |
5.4.1b | Informed consent and children's privacy | 0 |
5.4.2a | Legal awareness and prevention of harm | 0 |
5.4.2b | Informed consent content and voluntariness | 0 |
5.4.2c | Children's consent and community engagement | 0 |
5.4.2d | Limits to confidentiality and mandatory reporting | 0 |
6.1 | Introduction to adolescent sexual and reproductive health | 0 |
6.2 | Chapter objectives | 0 |
6.3.1a | Adolescent-friendly MISP implementation | 0 |
6.3.1b | Long-acting reversible contraception for adolescents | 0 |
6.3.2a | Partnership with adolescents in humanitarian action | 0 |
6.3.2b | Supporting adolescent-led response capacity | 0 |
6.3.3a | Adolescent-inclusive needs assessment | 0 |
6.3.3b | Inclusion of at-risk adolescents in assessments | 0 |
6.3.3c | Assessment of services, risks and protective factors | 0 |
6.3.3d | Knowledge of national adolescent SRH law | 0 |
6.3.4a | Institutional support for ASRH programmes | 0 |
6.3.4b | Tailoring programmes to adolescent sub-groups | 0 |
6.3.4c | Meaningful adolescent participation | 0 |
6.3.4d | Community involvement in ASRH programming | 0 |
6.3.4e | Privacy, confidentiality and non-discrimination | 0 |
6.3.4f | Linking HIV services with sexual and reproductive health | 0 |
6.3.4g | Provider sex of choice and GBV support | 0 |
6.3.5a | Addressing adolescent girls' greater vulnerability | 0 |
6.3.5b | Responding to disrupted social support | 0 |
6.3.5c | Building adolescents' future outlook and life skills | 0 |
6.3.5d | Supporting adolescents in adult roles | 0 |
6.3.5e | Evidence-based and coordinated ASRH programming | 0 |
6.3.6a | Applying WHO global standards for adolescents | 0 |
6.3.6b | Adolescent-responsive facility service package | 0 |
6.3.6c | Adolescent-responsive facility and provider practice | 0 |
6.3.6d | Individual adolescent screening and referral | 0 |
6.3.6e | Community-based ASRH delivery and outreach | 0 |
6.3.6f | School linkages, hygiene facilities and life skills | 0 |
6.3.6g | Adolescents in leadership and coordination | 0 |
6.3.7a | Referral systems from community settings | 0 |
6.3.7b | Multi-sectoral adolescent programming | 0 |
6.3.7c | Girls' empowerment and engaging boys and men | 0 |
6.3.8a | Advocacy with decision-makers | 0 |
6.3.8b | Donor and policymaker commitments | 0 |
6.3.8c | Health cluster prioritisation of ASRH | 0 |
6.3.8d | Preparedness and inclusive programme cycles | 0 |
6.3.8e | Mobilising community leaders and influencers | 0 |
6.4.1a | Adolescent rights under the CRC | 0 |
6.4.1b | Recognising rights violations in law and practice | 0 |
6.4.2a | Handling legal and ethical dilemmas | 0 |
6.4.2b | Refusing harmful examinations and procedures | 0 |
6.5a | Age and sex disaggregation of SRH indicators | 0 |
6.5b | Key adolescent SRH indicators | 0 |
7.1 | Chapter introduction and terminology | 0 |
7.2 | Chapter objectives | 0 |
7.3 | Overview of contraceptive programming | 0 |
7.3.1 | Principles for contraceptive programming | 0 |
7.3.2 | MISP priority activities for contraception | 0 |
7.3.3 | Situational information to guide kit orders | 0 |
7.3.3a | Assess and mobilise local provider capacity | 0 |
7.3.4a | Method mix and eligibility screening | 0 |
7.3.4b | Logistics, forecasting and supply chain | 0 |
7.3.4c | Facility-based contraceptive service standards | 0 |
7.3.4d | Community distribution and lay worker supervision | 0 |
7.3.5a | Provider qualifications and supervision | 0 |
7.3.5b | Quality standards and provider competence | 0 |
7.3.5c | Counselling and voluntary informed choice | 0 |
7.3.5d | Broad method mix and continuation support | 0 |
7.3.5e | Same visit, same location provision | 0 |
7.3.5f | Community engagement, social behaviour change and IEC | 0 |
7.3.6a | Contraceptive services for adolescents | 0 |
7.3.6b | Services for people who sell sex | 0 |
7.3.6c | Services for LGBTQIA people | 0 |
7.3.6d | Inclusion of persons with disabilities | 0 |
7.3.6e | Post-abortion contraception | 0 |
7.3.6f | Emergency contraception for rape survivors | 0 |
7.3.7 | Integration and coordination with other services | 0 |
7.3.8 | Advocacy for comprehensive family planning | 0 |
7.4 | Human rights and legal requirements | 0 |
7.5 | Monitoring and evaluation overview | 0 |
7.5.1 | Clinic and service register | 0 |
7.5.2 | Tracking and supporting continuation | 0 |
7.5.3 | Contraceptive service indicators | 0 |
8.1 | Chapter introduction and rationale | 0 |
8.2 | Chapter objectives and post-abortion care model | 0 |
8.3 | Integrated comprehensive abortion care and task-sharing | 0 |
8.3.1 | Safe abortion care within the MISP | 0 |
8.3.2a | Community and legal context assessment | 0 |
8.3.2b | Clinical capacity and supply assessment | 0 |
8.3.3a | Equitable access and values clarification | 0 |
8.3.3b | Provider competency and supportive supervision | 0 |
8.3.3c | Counseling, privacy and informed consent | 0 |
8.3.3d | Clinical assessment before uterine evacuation | 0 |
8.3.3e | Pain management for abortion procedures | 0 |
8.3.3f | Infection prevention and instrument processing | 0 |
8.3.3g | First-trimester abortion methods | 0 |
8.3.3h | Second-trimester abortion care | 0 |
8.3.3i | Post-abortion care methods | 0 |
8.3.3j | Complication management and tetanus prophylaxis | 0 |
8.3.3k | Post-procedure counseling and follow-up | 0 |
8.3.3l | Post-abortion contraception | 0 |
8.3.4 | Comprehensive abortion care across acute and recovery phases | 0 |
8.3.5a | Abortion care for adolescents | 0 |
8.3.5b | Abortion care for women who experienced violence | 0 |
8.3.5c | Abortion care for women living with HIV | 0 |
8.3.6a | Same-day contraception and SRH linkages | 0 |
8.3.6b | Routine violence inquiry and GBV referral | 0 |
8.3.6c | Conscientious objection and referral duty | 0 |
8.3.7 | Advocacy for comprehensive abortion care | 0 |
8.4 | Human rights and legal framework | 0 |
8.5a | Monitoring, evaluation and beneficiary feedback | 0 |
8.5b | Clinical register and confidentiality | 0 |
9.1 | Scope of maternal and newborn health | 0 |
9.2 | Chapter aims for MNH programming | 0 |
9.3.1 | Minimum emergency obstetric and newborn services | 0 |
9.3.2a | Transition to comprehensive MNH and quality | 0 |
9.3.2b | Clean delivery and newborn kit provision | 0 |
9.3.3a | Antenatal care contact package | 0 |